Special Drug Use Investigation for Arixtra (Fondaparinux) Venous Thromboembolism Treatment.
Phase of Trial: Phase IV
Latest Information Update: 17 Jul 2015
At a glance
- Drugs Fondaparinux sodium (Primary)
- Indications Deep vein thrombosis; Thromboembolism
- Focus Adverse reactions; Therapeutic Use
- Sponsors GlaxoSmithKline
- 14 Jul 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 24 Mar 2015 Status changed from not yet recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
- 24 Mar 2015 Planned End Date changed from 1 Oct 2014 to 1 May 2015, as reported by ClinicalTrials.gov.